Cytek Biosciences Inc (CTKB)vsGE HealthCare Technologies Inc. (GEHC)
CTKB
Cytek Biosciences Inc
$6.30
+2.61%
HEALTHCARE · Cap: $694.11M
GEHC
GE HealthCare Technologies Inc.
$75.82
+6.62%
HEALTHCARE · Cap: $34.25B
Smart Verdict
WallStSmart Research — data-driven comparison
GE HealthCare Technologies Inc. generates 10188% more annual revenue ($21.27B vs $206.71M). GEHC leads profitability with a 9.3% profit margin vs -39.0%. GEHC earns a higher WallStSmart Score of 65/100 (C+).
CTKB
Hold39
out of 100
Grade: F
GEHC
Buy65
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+39.4%
Fair Value
$7.20
Current Price
$6.30
$0.90 discount
Intrinsic value data unavailable for GEHC.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 73.5% YoY
Conservative balance sheet, low leverage
Reasonable price relative to book value
Attractively priced relative to earnings
Areas to Watch
Smaller company, higher risk/reward
ROE of -25.0% — below average capital efficiency
Negative free cash flow — burning cash
Currently unprofitable
Expensive relative to growth rate
Weak financial health signals
Negative free cash flow — burning cash
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : CTKB
The strongest argument for CTKB centers on EPS Growth, Debt/Equity, Price/Book.
Bull Case : GEHC
The strongest argument for GEHC centers on P/E Ratio.
Bear Case : CTKB
The primary concerns for CTKB are Market Cap, Return on Equity, Free Cash Flow.
Bear Case : GEHC
The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, Free Cash Flow.
Key Dynamics to Monitor
CTKB profiles as a turnaround stock while GEHC is a value play — different risk/reward profiles.
CTKB carries more volatility with a beta of 1.16 — expect wider price swings.
GEHC is growing revenue faster at 5.8% — sustainability is the question.
CTKB generates stronger free cash flow (-849,000), providing more financial flexibility.
Bottom Line
GEHC scores higher overall (65/100 vs 39/100). CTKB offers better value entry with a 39.4% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cytek Biosciences Inc
HEALTHCARE · MEDICAL DEVICES · USA
Cytek Biosciences Inc (CTKB) is a pioneering force in multi-parameter flow cytometry, delivering innovative cell analysis solutions that advance research in immunology, cancer diagnostics, and drug development. The company leverages its proprietary technologies to meet the growing demand for precision in cellular analytics, positioning itself as a key player in the biotechnology sector. With a robust product portfolio and a commitment to exceptional customer support, Cytek is well-equipped to drive transformative discoveries, ultimately enhancing healthcare outcomes and addressing critical challenges in the life sciences.
GE HealthCare Technologies Inc.
HEALTHCARE · MEDICAL DEVICES · USA
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?